Paul B. Manning - Insider Trading & Ownership

Entity
Individual
Location
200 Garrett Street Suite S, Charlottesville, VA
Summary
The estimated net worth of Paul B. Manning is at least $162M dollars as of December 18, 2024. Paul B. Manning is the Director, 10%+ Owner of Verrica Pharmaceuticals Inc. and owns shares of Verrica Pharmaceuticals Inc. (VRCA) stock worth about $86.4M. Paul B. Manning is the Director of Liquidia Corp and owns shares of Liquidia Corp (LQDA) stock worth about $35.1M. Paul B. Manning is the Director of Candel Therapeutics, Inc. and owns shares of Candel Therapeutics, Inc. (CADL) stock worth about $24.8M. Paul B. Manning is the 10%+ Owner of Taysha Gene Therapies, Inc. and owns shares of Taysha Gene Therapies, Inc. (TSHA) stock worth about $13.9M. Paul B. Manning is the 10%+ Owner of Acumen Pharmaceuticals, Inc. and owns shares of Acumen Pharmaceuticals, Inc. (ABOS) stock worth about $2.28M.
All Insider Reports
All Insider Reports

Ownership of Paul B. Manning

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VRCA Verrica Pharmaceuticals Inc. Director, 10%+ Owner $86.4M Nov 22, 2024
LQDA Liquidia Corp Director $35.1M +$3M +9.33% Sep 12, 2024
CADL Candel Therapeutics, Inc. Director $24.8M +$7.5M +43.4% Dec 16, 2024
TSHA Taysha Gene Therapies, Inc. 10%+ Owner $13.9M +$3M +27.6% Jun 27, 2024
ABOS Acumen Pharmaceuticals, Inc. 10%+ Owner $2.28M Jul 6, 2021

Insider Transactions Reported by Paul B. Manning:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.